Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 11/20 | 0.40 |
| ▸ | SLC5A1 | P13866 | 4/20 | 0.34 |
| ▸ | SLC5A2 | P31639 | 4/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20870247 | 1.00 | SELP (0.40) | SELPSLC5A1SLC5A2PPARGPPARD | |
| SCHEMBL21757439 | 0.94 | PPARG (0.41) | SELPSLC5A1SLC5A2PPARGPPARD | |
| SCHEMBL19441496 | 0.94 | PPARG (0.41) | SELPSLC5A1SLC5A2PPARGPPARD | |
| SCHEMBL20870541 | 0.94 | PPARG (0.41) | SELPSLC5A1SLC5A2PPARGPPARD | |
| SCHEMBL19818859 | 0.94 | PPARG (0.41) | SELPSLC5A1SLC5A2PPARGPPARD | |
| SCHEMBL16559174 | 0.90 | SELP (0.44) | SELP | |
| SCHEMBL19441497 | 0.90 | SELP (0.43) | SELPSLC5A1SLC5A2PPARGPPARD | |
| SCHEMBL21167735 | 0.90 | SELP (0.43) | SELPSLC5A1SLC5A2PPARGPPARD | |
| SCHEMBL20870540 | 0.90 | SELP (0.43) | SELPSLC5A1SLC5A2PPARGPPARD | |
| SCHEMBL20870546 | 0.89 | SELP (0.39) | SELPSLC5A1SLC5A2PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10918714-B2 | Human iNKT cell activation using glycolipids with altered glycosyl groups | ACADEMIA SINICA (TW) | 2021-02-16 | — | — | US | disclosed |
| US-9879042-B2 | Human iNKT cell activation using glycolipids | ACADEMIA SINICA (TW) | 2018-01-30 | — | — | US | disclosed |
| US-9782476-B2 | Human iNKT cell activation using glycolipids with altered glycosyl groups | ACADEMIA SINICA (TW) | 2017-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10918714-B2 | Human iNKT cell activation using glycolipids with altered glycosyl groups | UGCG, GALK1, B3GAT3 | SELP 722/4885SLC5A1 341/4885SLC5A2 430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.